The stock price and market valuation of Globus Medical (NYSE: GMED) are influenced by a variety of fundamental financial metrics, including quarterly revenue growth, surgeon adoption rates of its robotic navigation systems like ExcelsiusGPS, gross margin expansions, and successful product commercialization pipelines. Additionally, broader macroeconomic variables—such as healthcare sector spending trends, regulatory approvals from agencies like the FDA, competitive pressures within the med-tech industry, and overall institutional investor sentiment toward medical technology equities—play a critical role in shaping share performance.